Latest News and Events

GeoVax Reports 2015 Second Quarter Financial Results and Provides Corporate Update
Ebola Vaccine Preclinical Data to be Released Late Summer Clade B HIV Vaccine Clinical Trial (HVT...
Continue Reading...
GeoVax Receives Grant from NIH for HIV Vaccine Program
Supports Development of an Innovative Approach to HIV Prevention for Clade C HIV that is Prevalen...
Continue Reading...
African Leadership Magazine to Present Two Prestigious Awards to GeoVax and Dr. Robert McNally
GeoVax’s Efforts to Develop HIV/AIDS and Ebola Vaccines Recognized   GeoVax Labs, Inc. (O...
Continue Reading...

Dr. Harriet Robinson, Ph.D. ASM Lecture